Non Small Cell Lung Cancer Five Year Survival Overall Survival: SIH 16.6% (12.2-20.9) All NCDB 16.7% (16.6-16.8) 100.0% 90.0% 80.0% 70.0% 60.0% 50.0% 40.0% 30.0% 20.0% 10.0% 0.0%
Stage I
Stage II
Stage III
Stage IV
Overall
All NCDB SIH
Overall Five Year Survival by Primary Site, 2003-2006 Site
SIH %
All NCDB %
Breast
83.0 (79.0-86.9)
85.5 (85.4-85.6)
Non Small Cell Lung
16.6 (12.2-20.9)
16.7 (16.6-16.8)
All Head/Neck
50.3 (37.1-63.5)
53.6 (53.2-54.0)
All Colorectal
50.5 (43.1-57.9)
56.6 (56.4-56.7)
All Digestive
38.6 (32.5-44.6)
40.8 (40.6-40.9)
Lymphoma
63.8 (48.4-79.1)
63.2 (62.9-63.4)
All Male Genital
81.4 (75.2-87.6)
88.0 (87.9-88.1)
All Female Genital
66.5 (51.3-81.8)
65.1 (64.9-65.4)
Urinary
43.1 (30.7-55.4)
62.7 (62.5-62.9)
17